+91 94 2742 1234

News & Updates

27
Apr
2017
USFDA issues warning letter to Divis Labs for Vizag unit

Drug firm Divis Laboratories today said the US health regulator has issued a warning letter to the company for its Vishakhapatnam facility.

The United States Food and Drug Administration (USFDA) has issued warning letter for the company's Unit-II at Vishakhapatnam, Divis Laboratories said in a BSE filing.

 

The company along with external consultants and subject matter experts is working to address the concerns of USFDA and is making all efforts to fully meet the compliance requirements, it added.

The company, however, did not provide details of the warning letter.

Copyright © Amizara Distributors. All rights reserved. | Designed & Developed By : www.pcubedesign.com